Please ensure Javascript is enabled for purposes of website accessibility

Marijuana Stocks: A Real Investing Opportunity or Not Worth the Hype?

By Max Macaluso – Feb 13, 2014 at 1:45PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There has been a lot of hype around marijuana stocks lately, but is this market too immature to invest in today?

According to an oft-cited report by ArcView Market Research, the legal marijuana market may top $2.3 billion in sales this year. Investors have undoubtedly been keeping a close eye on this market, but note that this is the potential size of the marijuana sales. This industry faces a number of challenges that could hinder its growth, including regulatory threats and the broader debate over decriminalizing use of the drug. While restrictions on marijuana have been eased in some states, it's important to remember that the drug is illegal at the federal level. Additionally, many marijuana stocks are incredibly risky penny stocks, and the Financial Industry Regulatory Authority has even issued a warning that investors must beware of marijuana stock scams.

In the following video, part of The Motley Fool's "Ask a Fool" series, health care analyst Max Macaluso takes a close look at marijuana stocks and stresses that, while the potential market size may look attractive, investors must be wary; he believes that the industry is simply too immature to invest in today. He also sheds light on GW Pharmaceuticals (GWPH), a biotech company that many refer to as a "marijuana stock."

Max Macaluso, Ph.D. has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Stocks Mentioned

GW Pharmaceuticals Stock Quote
GW Pharmaceuticals
GWPH

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.